CN112961262A - Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof - Google Patents
Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof Download PDFInfo
- Publication number
- CN112961262A CN112961262A CN202110404688.XA CN202110404688A CN112961262A CN 112961262 A CN112961262 A CN 112961262A CN 202110404688 A CN202110404688 A CN 202110404688A CN 112961262 A CN112961262 A CN 112961262A
- Authority
- CN
- China
- Prior art keywords
- passion fruit
- fruit peel
- polysaccharide
- acidic polysaccharide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000288157 Passiflora edulis Species 0.000 title claims abstract description 79
- 235000000370 Passiflora edulis Nutrition 0.000 title claims abstract description 79
- 229920001284 acidic polysaccharide Polymers 0.000 title claims abstract description 47
- 150000004805 acidic polysaccharides Chemical class 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 29
- 239000005017 polysaccharide Substances 0.000 claims abstract description 29
- 150000004804 polysaccharides Chemical class 0.000 claims abstract description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 7
- 238000002791 soaking Methods 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 6
- 238000004587 chromatography analysis Methods 0.000 claims abstract 2
- 239000003480 eluent Substances 0.000 claims description 13
- 238000004108 freeze drying Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- 235000011925 Passiflora alata Nutrition 0.000 claims description 4
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 4
- 235000013750 Passiflora mixta Nutrition 0.000 claims description 4
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000013375 chromatographic separation Methods 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 29
- 235000000346 sugar Nutrition 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 13
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 11
- 238000005342 ion exchange Methods 0.000 abstract description 8
- 230000001603 reducing effect Effects 0.000 abstract description 6
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 55
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 23
- 102000004877 Insulin Human genes 0.000 description 14
- 108090001061 Insulin Proteins 0.000 description 14
- 229940125396 insulin Drugs 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 235000021316 daily nutritional intake Nutrition 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- UBXYXCRCOKCZIT-UHFFFAOYSA-N biphenyl-3-ol Chemical group OC1=CC=CC(C=2C=CC=CC=2)=C1 UBXYXCRCOKCZIT-UHFFFAOYSA-N 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 235000021051 daily weight gain Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001019 normoglycemic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Sustainable Development (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses passion fruit peel acidic polysaccharide, a preparation method and application thereof, and belongs to the technical field of plant extraction and medicines. The preparation method of the passion fruit peel acidic polysaccharide comprises the following steps: pulverizing passion fruit peel, adding ethanol, condensing, reflux-extracting, collecting residue, drying, soaking in water, extracting, mixing extractive solutions, concentrating, cooling, adding 95% ethanol, precipitating, and centrifuging to obtain passion fruit peel crude polysaccharide; performing chromatography with DEAE cellulose ion exchange column, sequentially eluting with distilled water and NaCl solution, separating and purifying to obtain passion fruit peel acidic polysaccharide. The passion fruit peel acidic polysaccharide prepared by the method has the activity of reducing blood sugar, and can be used as a medicine for treating diabetes.
Description
Technical Field
The invention relates to passion fruit peel acidic polysaccharide, a preparation method and application thereof, and belongs to the field of plant extraction and the technical field of medicines.
Background
Polysaccharides are sugars which are present in nature in abundant resources, and are widely present in organisms such as plants, animals, and microorganisms. The polysaccharide as a natural polymer extract almost without toxic and side effects has unique effects in preventing and treating many diseases, especially some stubborn diseases and stubborn diseases, such as tumors, hypoimmunity, hyperglycemia, aging, viral diseases and the like.
Passiflora edulis, also known as passion fruit, is a subtropical special fruit, has high fruit pulp acidity, rich flavor and rich nutrition, and is an excellent subtropical fruit juice processing raw material. However, after the pulp is processed by the passion flower processing industry, the vast majority of the peel is discarded. The fruit peel as the processing waste accounts for about 50 percent of the whole passion fruit, the waste of the fruit peel not only increases the enterprise cost and reduces the benefit, but also wastes a large amount of agricultural resources and pollutes the environment, and the utilization of the fruit peel is very necessary and significant. The existing research shows that the polysaccharide in the passion fruit peel is one of the main functional components, and is highly concerned by scholars at home and abroad because the passion fruit peel has multiple active functions of antianxiety, sedation, anti-inflammation, anti-addiction, antioxidation, cell immunity enhancement, tumor inhibition, blood sugar reduction and the like. It has been demonstrated that polysaccharides have a wide range of biological effects, and are directly related to acidic polysaccharides contained therein, which are the main components for their functions, and the amount of sulfate groups contained in the polysaccharides determines the strength and weakness of the functions of the polysaccharides.
The passion fruit peel is a abundant biological material which is abandoned by the food processing industry, and although the activity of polysaccharide ingredients in the passion fruit peel is researched at present, the extraction preparation of the main active ingredient acidic polysaccharide and the biological function of the acidic polysaccharide are researched less. Therefore, the development of the passion fruit peel not only can change waste into valuable to obtain economic benefits, but also can improve the environment to obtain good social benefits, and more importantly, the development of the potential medicinal value of the passion fruit peel has profound significance and broad prospect for fully utilizing resources and expanding medicine sources.
Disclosure of Invention
The first purpose of the invention is to provide a preparation method of passion fruit peel acidic polysaccharide.
The second purpose of the invention is to provide the passion fruit peel acidic polysaccharide prepared by any one of the preparation methods.
The third purpose of the invention is to provide the application of the passion fruit peel acidic polysaccharide in preparing a pharmaceutical composition.
A fourth object of the present invention is to provide a pharmaceutical composition.
In order to achieve the purpose, the invention provides the following scheme:
a preparation method of passion fruit peel acidic polysaccharide comprises the following steps:
(1) pulverizing dried passion fruit peel, sieving, extracting with 80% ethanol under reflux, collecting residue, and drying;
(2) mixing the residue obtained in the step (1) with water according to a feed-liquid ratio of 1 g: mixing 16mL of the mixed solution, soaking overnight, extracting, combining concentrated extracting solutions, cooling, and adding 95% ethanol with three times of volume;
(3) filtering the ethanol precipitated extracting solution prepared in the step (2), centrifuging, and freeze-drying the precipitate to obtain crude passion fruit peel polysaccharide;
(4) and (3) dissolving the passion fruit peel crude polysaccharide obtained in the step (3) in Water, carrying out DEAE-cellulose ion exchange chromatography column chromatography separation, eluting with distilled Water, discarding the eluent, eluting with a chloride solution, collecting the eluent, concentrating, dialyzing, and freeze-drying to obtain the passion fruit peel acidic polysaccharide (WPEP).
Further, in the step (1), the extraction is performed for 1-3 times by condensation reflux, and each time lasts for 1-3 hours.
Further, the extraction temperature in the step (2) is 90-120 ℃, and the extraction is carried out for 1-3 times, 2-4 hours each time.
Further, in the step (3), the filtered extracting solution is centrifuged for 10-20 min under the condition of 3000-5000 rpm.
Further, in the step (4), the elution flow rate is 15mL/min, the chloride solution is 0.7mol/L NaCl solution, and the running water dialysis is carried out for 48 hours.
Further, the chromatographic separation in the step (4) adopts a CL-type DEAE-cellulose ion exchange chromatographic column.
Meanwhile, the invention claims the passion fruit peel acidic polysaccharide prepared by the preparation method.
Furthermore, the invention claims the application of the passion fruit peel acidic polysaccharide in the preparation of hypoglycemic drugs or health care products.
Furthermore, the dosage form of the medicine or the health care product is tablets, granules, hard capsules, soft capsules, oral liquid, powder, mixture or pills.
The invention also claims a pharmaceutical composition which contains the passion fruit peel acidic polysaccharide and a pharmaceutically acceptable carrier or auxiliary material.
The invention discloses the following technical effects:
1) the invention innovatively utilizes the passion fruit peel biomass resources at a high value to prepare the passion fruit peel acidic polysaccharide with the blood sugar reducing effect, and the prepared passion fruit peel acidic polysaccharide has a good application prospect.
2) The method comprises the steps of alcohol extraction, water extraction, alcohol precipitation, precipitation centrifugation and the like, impurities in passion fruit peel and proteins, carbohydrates, flavones, cellulose, polyphenols and the like contained in the passion fruit peel are separated, DEAE cellulose ion exchange column chromatography is used, elution is carried out by using distilled water, neutral polysaccharide is eluted to achieve the purpose of coarse extraction and fine extraction, then sodium chloride solution with the concentration of 0.7mol/L is used for eluting acid polysaccharide, and the concentrated eluent is subjected to running water dialysis, so that sodium chloride and micromolecular impurities in the acid polysaccharide can be removed.
3) The method for preparing the passion fruit peel acidic polysaccharide is to stir at a certain temperature and extract by DEAE cellulose ion exchange column chromatography, saves intermediate steps for removing protein and other small molecular impurities, reduces extraction time and improves utilization rate compared with the traditional extraction process.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings needed to be used in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings without inventive exercise.
FIG. 1 is a graph showing the change in daily food intake of mice in each group;
FIG. 2 is a graph showing the change in daily weight gain of mice in each group;
FIG. 3 is the blood glucose levels in the mice of each group during the first week;
FIG. 4 is the blood glucose levels in the four week group of mice;
FIG. 5 shows the serum insulin levels of the mice of the fourth week group;
FIG. 6 shows the serum Triglyceride (TG) content of mice in the peripheral groups;
FIG. 7 is a graph showing the change in blood glucose values after each group of mice received insulin.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference herein for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the present disclosure without departing from the scope or spirit of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification. The description and examples are intended to be illustrative only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are open-ended terms that mean including, but not limited to.
The method for measuring the uronic acid content, daily feed intake, daily weight gain, blood sugar content, insulin content in serum, triglyceride content and blood sugar level in the passion fruit peel acidic polysaccharide in the animal experiment is a conventional technical means in the field, is not an inventive main point, and is not described herein any more.
The percentage numbers of the 95% ethanol, the 80% ethanol and the like are volume fractions unless otherwise specified.
The technical solution of the present invention is further illustrated by the following examples.
Extraction and determination of passion fruit peel acidic polysaccharide
Example 1
(1) Pulverizing 100g dried passion fruit peel, sieving, extracting with 80% ethanol at 85 deg.C under reflux for 3 times, each for 2 hr, collecting residue, and drying; taking the residue and water according to the material-liquid ratio of 1 g: mixing 16mL of the raw materials, soaking overnight, extracting for 2 times at 90 ℃ for 4 hours each time, mixing the extracting solutions, concentrating the extracting solution to be viscous, cooling, and adding 95% ethanol with three times of volume; filtering the ethanol precipitated extractive solution, centrifuging at 4000rpm for 15min, and freeze drying the precipitate to obtain crude Passiflora edulis pericarp polysaccharide;
(2) dissolving 2g of crude passion fruit peel polysaccharide in 200mdL water, loading the crude passion fruit peel polysaccharide on a CL-type DEAE-cellulose ion exchange chromatographic column, eluting with distilled water at the flow rate of 15mL/min, discarding the eluent, eluting with a NaCl aqueous solution with the concentration of 0.7mol/L, collecting the eluent, concentrating, dialyzing with running water for 48h, and freeze-drying to obtain 0.228g of passion fruit peel acidic polysaccharide (WPEP-2), wherein the yield is 11.4%;
(3) the content of uronic acid in the passion fruit peel acidic polysaccharide is determined by adopting an m-hydroxybiphenyl method, and the purity of the obtained acidic polysaccharide is 77.14%.
Example 2
(1) Pulverizing 100g dried passion fruit peel, sieving, extracting with 80% ethanol at 85 deg.C under reflux for 3 times, each for 2 hr, collecting residue, and drying; taking the residue and water according to the material-liquid ratio of 1 g: mixing 16mL of the raw materials, soaking overnight, extracting for 2 times at 100 ℃ for 3 hours each time, mixing the extracting solutions, concentrating the extracting solution to be viscous, cooling, and adding 95% ethanol with three times of volume; filtering the ethanol precipitated extractive solution, centrifuging at 4000rpm for 15min, and freeze drying the precipitate to obtain crude Passiflora edulis pericarp polysaccharide;
(2) dissolving 2g of crude passion fruit peel polysaccharide in water, loading the crude passion fruit peel polysaccharide to a CL-type DEAE-cellulose ion exchange chromatographic column, eluting with distilled water at the flow rate of 15mL/min, discarding the eluent, sequentially eluting with a NaCl aqueous solution with the concentration of 0.7mol/L, collecting the eluent for concentration, dialyzing with running water for 48 hours, and freeze-drying to obtain 0.206g of passion fruit peel acidic polysaccharide (WPEP-2), wherein the yield is 10.3%;
(3) the content of uronic acid in the passion fruit peel acidic polysaccharide is determined by adopting an m-hydroxybiphenyl method, and the purity of the obtained acidic polysaccharide is 75.03%.
Example 3
(1) Pulverizing 100g dried passion fruit peel, sieving, extracting with 80% ethanol at 85 deg.C under reflux for 3 times, each for 2 hr, collecting residue, and drying; taking the residue and water according to the material-liquid ratio of 1 g: mixing 16mL of the raw materials, soaking overnight, extracting for 2 times at 100 ℃ for 3 hours each time, mixing the extracting solutions, concentrating the extracting solution to be viscous, cooling, and adding 95% ethanol with three times of volume; filtering the ethanol precipitated extractive solution, centrifuging at 5000rpm for 10min, and freeze drying the precipitate to obtain crude Passiflora edulis pericarp polysaccharide;
(2) dissolving 2g of crude passion fruit peel polysaccharide in water, loading the crude passion fruit peel polysaccharide to a CL-type DEAE-cellulose ion exchange chromatographic column, eluting with distilled water at the flow rate of 15mL/min, discarding the eluent, sequentially eluting with a NaCl aqueous solution with the concentration of 0.7mol/L, collecting the eluent for concentration, dialyzing with running water for 48 hours, and freeze-drying to obtain 0.215g of passion fruit peel acidic polysaccharide (WPEP-2), wherein the yield is 10.8%;
(3) the content of uronic acid in the passion fruit peel acidic polysaccharide is determined by adopting an m-hydroxybiphenyl method, and the purity of the obtained acidic polysaccharide is 72.33%.
Example 4
(1) Pulverizing 100g dried passion fruit peel, sieving, extracting with 80% ethanol at 85 deg.C under reflux for 3 times, each for 2 hr, collecting residue, and drying; taking the residue and water according to the material-liquid ratio of 1 g: mixing 16mL of the raw materials, soaking overnight, extracting for 1 time at 100 ℃ for 2 hours each time, mixing the extracting solutions, concentrating the extracting solution to be viscous, cooling, and adding 95% ethanol with three times of volume; filtering the ethanol precipitated extractive solution, centrifuging at 3000rpm for 10min, and freeze drying the precipitate to obtain crude Passiflora edulis pericarp polysaccharide;
(2) dissolving 2g of crude passion fruit peel polysaccharide in water, loading the crude passion fruit peel polysaccharide to a CL-type DEAE-cellulose ion exchange chromatographic column, eluting with distilled water at the flow rate of 15mL/min, discarding the eluent, sequentially eluting with a NaCl aqueous solution with the concentration of 0.7mol/L, collecting the eluent for concentration, dialyzing with running water for 48 hours, and freeze-drying to obtain 0.192g of passion fruit peel acidic polysaccharide (WPEP-2), wherein the yield is 9.6%;
(3) the content of uronic acid in the passion fruit peel acidic polysaccharide is determined by adopting an m-hydroxybiphenyl method, and the purity of the obtained acidic polysaccharide is 71.4%.
Second, evaluation of hypoglycemic action of passion fruit peel acidic polysaccharide
Animal experiments:
the experiment shared 30 mice, among which the normal blood sugar mice: 5, diabetic mice: 25 are provided. 5 mice of normoglycemic mice were used as the normal group; diabetic mice were randomly divided into five groups of 5 mice each, each group being: model control group, positive control group, WPEP-2 low dose group, WPEP-2 medium dose group and WPEP-2 high dose group, mice freely drink water and food during feeding period.
And groups of mice were treated as follows:
NC: in the normal group, C57BLKS/JNju mice are subjected to distilled water intragastric administration;
MC: performing stomach irrigation treatment on a model control group and db/db mice by using distilled water;
PC: in the positive control group, the metformin lavage treatment is carried out on db/db mice, and the dosage is 50 mg/kg/d;
l: in the low-dose group, the WPEP-2 of db/db mice is subjected to intragastric administration, and the dose is 50 mg/kg/d;
m: in the middle dose group, the WPEP-2 of db/db mice is treated by gastric lavage, and the dose is 100 mg/kg/d;
h: in the high-dose group, db/db mice are subjected to WPEP-2 intragastric administration, and the dose is 200 mg/kg/d.
(1) Measurement of daily food intake
The effect of WPEP-2 on the daily food intake of diabetic mice was studied, and the change curve of the daily food intake of each group of mice is shown in FIG. 1. The food intake of the mice in each group during week 4 is shown in Table 1, wherein the food intake of the positive control group during week 4 is 40.08g/d, which is lower than the food intake of the model control group; the intake of the mice in the WPEP-2 treatment group is lower than that of the model control group, and the daily intake of the mice in the low, medium and high dose groups is 55.15 g/d, 50.24g/d and 45.50g/d respectively. It is demonstrated that WPEP-2 can reduce the daily food intake of mice.
TABLE 1
(2) Determination of daily weight gain
The daily gain of body weight of each group of mice is shown in FIG. 2. The initial and post-experiment body weights of each group of mice are shown in table 2, wherein the initial weights of each group of diabetic mice are higher than those of the normal group; after the experiment (week 4), the weight average of each group showed different increases, and the weight of the normal group mice and the model control group mice increased 11.89% and 32.84% respectively compared with week 1, and the weight of the low, medium and high dose groups and the positive control group increased 29.67%, 32.62%, 28.57% and 33.47% respectively. It is shown that WPEP-2 can reduce the body weight of diabetic mice.
TABLE 2
(3) Measurement of blood glucose in mice
In vivo, the effect of WPEP-2 on changes in blood glucose was studied, and the blood glucose levels in mice in groups at week 1 are shown in FIG. 3, and in mice in groups at week 4 are shown in FIG. 4. The blood sugar content of the mice in each group at week 1 and week 4 is shown in table 3, the blood sugar level of the mice in the normal group is lower than that of the control group of the model, and the difference is very obvious (P < 0.001); the blood sugar level of the mice in the positive control group and the high-dose group is lower than that of the mice in the model control group, and the difference is very obvious (P < 0.01); the blood sugar level of mice in the low-dose group and the medium-dose group is lower than that of the model control group, and the difference is obvious (P < 0.05). Compared with the model control group, the WPEP-2 dry prognosis, the low dose, the medium dose and the high dose groups respectively reduce the blood sugar level of the mice by 32.49 percent, 32.70 percent and 36.60 percent. It is shown that WPEP-2 has the effect of lowering blood sugar level.
TABLE 3
(4) Determination of the Effect of WPEP-2 on insulin and Triglycerides (TG) in the serum of mice
The serum insulin levels of the mice in each group at week 4 are shown in FIG. 5. Compared with the model control group, the insulin levels of the mice in the medium and high dose groups are respectively reduced by 40.93 percent and 44.81 percent, and the effect is similar to that of the positive control group (37.77 percent). The WPEP-2 low dose group also has the effect of reducing blood sugar, but the reduction rate is 23.78 percent without obvious medium and high dose groups. It was shown that WPEP-2 reduces insulin resistance in diabetic mice.
The serum Triglyceride (TG) content of each group of mice at week 4 is shown in FIG. 6. The serum triglyceride of the normal group is obviously lower than that of the model control group, and the difference is extremely obvious (P < 0.01); after treatment with metformin and low, medium and high doses of WPEP-2, TG levels were significantly reduced in diabetic mice. It was shown that a medium or high dose of WPEP-2 has a potential effect on improving lipid levels. Table 4 shows the serum insulin and triglyceride levels of the mice at week 4.
TABLE 4
(5) Mouse insulin resistance (ITT) assay
The change curve of blood glucose value after each group of mice injected with 0.5U/kg insulin is shown in FIG. 7, and the blood glucose values before and after injection are shown in Table 5. Compared with the blood glucose value at 0, the blood glucose values of mice in the low, medium and high dose groups, the model control group and the positive control group are reduced by 22.51%, 14.57%, 2.46%, 24.23% and 29.07% at 30 min. It is shown that the low dose and the medium dose of WPEP-2 can reduce the insulin resistance of diabetic mice and delay the disease condition.
TABLE 5
Diabetes is a highly metabolic disease, and a patient may eat more food to increase blood sugar content, but the insufficient secretion of insulin makes the blood sugar not be used effectively, but only glycogen of the patient is decomposed, resulting in lipid metabolism disorder. According to the invention, the low, medium and high doses of passion fruit peel acidic polysaccharide are injected to sick mice, so that the feed intake of the mice is effectively controlled, and the problems of weight increase and high blood sugar value caused by the rise of the blood sugar content are solved; the level of insulin in serum of an insulin resistant mouse is relatively high, but the insulin can not play a role in reducing blood sugar due to the resistance of the mouse to the insulin, the content of the insulin in the serum of the mouse can be reduced by injecting different amounts of passion fruit peel acidic polysaccharide, the effects of reducing the insulin resistance of a diabetic mouse and relieving the disease condition are achieved, and the passion fruit peel acidic polysaccharide prepared by the method has a good blood sugar reducing effect through the effect verification.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (10)
1. A preparation method of passion fruit peel acidic polysaccharide is characterized by comprising the following steps:
(1) pulverizing dried passion fruit peel, sieving, extracting with ethanol under reflux, collecting residue, and drying;
(2) mixing the residue obtained in the step (1) with water according to a feed-liquid ratio of 1 g: mixing 10-20mL of the mixture, soaking overnight and extracting, combining concentrated extracting solutions, cooling, and adding ethanol with three times of volume to obtain an ethanol-precipitated extracting solution;
(3) filtering the ethanol precipitated extracting solution prepared in the step (2), centrifuging, and freeze-drying the precipitate to obtain crude passion fruit peel polysaccharide;
(4) and (3) dissolving the crude passion fruit peel polysaccharide obtained in the step (3) in water, carrying out chromatographic separation, eluting with distilled water, discarding the eluent, eluting with a chloride solution, collecting the eluent, concentrating, dialyzing, and freeze-drying to obtain the acidic passion fruit peel polysaccharide.
2. The preparation method of the passion flower pericarp acidic polysaccharide as claimed in claim 1, wherein the condensation reflux extraction in step (1) is performed for 1-3 times, each time for 1-3 hours.
3. The preparation method of the passion flower pericarp acidic polysaccharide as claimed in claim 1, wherein the extraction temperature in the step (2) is 90-120 ℃, and the extraction is carried out for 1-3 times, each time for 2-4 hours.
4. The method for preparing the passion fruit peel acidic polysaccharide in claim 1, wherein in the step (3), the filtered extracting solution is centrifuged at 3000-5000 rpm for 10-20 min.
5. The preparation method of the passion fruit peel acidic polysaccharide of claim 1, wherein the elution flow rate in the step (4) is 15mL/min, the chloride solution is 0.7mol/L NaCl solution, and the running water dialysis is performed for 48 h.
6. The method for preparing the passion flower pericarp acidic polysaccharide as claimed in claim 1, wherein the chromatography separation in step (4) adopts CL-type DEAE-cellulose ion exchange chromatography column.
7. The passion fruit peel acidic polysaccharide prepared by the preparation method of any one of claims 1-6.
8. The use of the passion fruit peel acidic polysaccharide of claim 7 in the preparation of a hypoglycemic medicament or health product.
9. The use of claim 8, wherein the pharmaceutical or nutraceutical is in the form of tablet, granule, hard capsule, soft capsule, oral liquid, powder, mixture or pill.
10. A pharmaceutical composition comprising the acidic passion fruit peel polysaccharide of claim 7 as an active ingredient, together with a pharmaceutically acceptable carrier or excipient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110404688.XA CN112961262A (en) | 2021-04-15 | 2021-04-15 | Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110404688.XA CN112961262A (en) | 2021-04-15 | 2021-04-15 | Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112961262A true CN112961262A (en) | 2021-06-15 |
Family
ID=76280428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110404688.XA Pending CN112961262A (en) | 2021-04-15 | 2021-04-15 | Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112961262A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113354752A (en) * | 2021-06-16 | 2021-09-07 | 桂林理工大学 | Preparation method and application of alkali-extracted polysaccharide for improving antioxidation effect of passion fruit peel polysaccharide |
CN114190555A (en) * | 2021-12-18 | 2022-03-18 | 江苏艾兰得营养品有限公司 | Drop pills with antioxidation efficacy and preparation method thereof |
CN115260327A (en) * | 2022-08-02 | 2022-11-01 | 桂林理工大学 | Passion fruit peel polysaccharide with weight-losing and lipid-lowering effects and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107793494A (en) * | 2017-12-02 | 2018-03-13 | 桂林理工大学 | Passion flower-fruit peel polysaccharide extracting process and response surface optimization method |
CN113354752A (en) * | 2021-06-16 | 2021-09-07 | 桂林理工大学 | Preparation method and application of alkali-extracted polysaccharide for improving antioxidation effect of passion fruit peel polysaccharide |
-
2021
- 2021-04-15 CN CN202110404688.XA patent/CN112961262A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107793494A (en) * | 2017-12-02 | 2018-03-13 | 桂林理工大学 | Passion flower-fruit peel polysaccharide extracting process and response surface optimization method |
CN113354752A (en) * | 2021-06-16 | 2021-09-07 | 桂林理工大学 | Preparation method and application of alkali-extracted polysaccharide for improving antioxidation effect of passion fruit peel polysaccharide |
Non-Patent Citations (2)
Title |
---|
GUAN YUAN等: ""Physicochemical characterization and the hypoglycemia effects of polysaccharide isolated from Passiflora edulis Sims peel"", 《FOOD FUNCTION》, vol. 12, no. 9, 20 March 2021 (2021-03-20), pages 4221 - 4230 * |
李晗 等: ""超声辅助酶法提取西番莲果皮可溶性膳食纤维及理化性质"", 《食品工业科技》, vol. 41, no. 7, 31 July 2020 (2020-07-31), pages 161 - 166 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113354752A (en) * | 2021-06-16 | 2021-09-07 | 桂林理工大学 | Preparation method and application of alkali-extracted polysaccharide for improving antioxidation effect of passion fruit peel polysaccharide |
CN114190555A (en) * | 2021-12-18 | 2022-03-18 | 江苏艾兰得营养品有限公司 | Drop pills with antioxidation efficacy and preparation method thereof |
CN114190555B (en) * | 2021-12-18 | 2023-06-23 | 江苏艾兰得营养品有限公司 | A dripping pill with antioxidant effect and its preparation method |
CN115260327A (en) * | 2022-08-02 | 2022-11-01 | 桂林理工大学 | Passion fruit peel polysaccharide with weight-losing and lipid-lowering effects and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112961262A (en) | Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof | |
CN108785342B (en) | Moringa oleifera leaf extract with hypoglycemic activity and preparation method thereof | |
CN108477612B (en) | Dendrobium nutrition powder containing dendrobium officinale purified extract and preparation method thereof | |
KR20050109269A (en) | A ginseng preparation using vinegar and process for thereof | |
CN1723981A (en) | Novel use of extractive of Momordica grosvenori as adjuvant drug for preparing medicine | |
CN102702582A (en) | Zeamays L. polysaccharide and preparation method and application thereof | |
CN111700902B (en) | Hawthorn procyanidine-jujube polysaccharide composition and preparation method thereof | |
CN109939143A (en) | A kind of Chinese medicine composition and preparation method thereof for hypoglycemic control complication | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN111568948A (en) | Application of mulberry extract in preparing medicine for improving pancreatic islet function | |
CN1861637A (en) | Preparation process of Huai Chinese yam polysaccharose and use thereof | |
CN106265717B (en) | Application of the dicliptera chinensis polysaccharide in preparing prevention diabetes medicament or health products | |
CN112979839A (en) | Preparation method of passion flower leaf acidic polysaccharide | |
CN102028703B (en) | New application of inulin | |
CN114533817A (en) | Composition for improving blood sugar and/or blood fat and application thereof | |
CN106589083B (en) | Coriolus versicolor glycopeptide active ingredient PSK-1c1 for treating alcoholic liver disease | |
CN112219923A (en) | Preparation and application of rosa roxburghii tratt edible fungus tea fermented beverage capable of reducing blood fat and blood sugar | |
CN113980152B (en) | Inonotus obliquus homogeneous polysaccharide and preparation method and application thereof | |
CN114831309B (en) | Lucid ganoderma and American ginseng composition and preparation method and application thereof | |
CN113880960B (en) | Anti-hypoxia active dendrobium officinale polysaccharide and steam explosion preparation method and application thereof | |
CN114292343B (en) | Preparation method of perennial cerasus extracellular polysaccharide and intracellular polysaccharide and application of perennial cerasus extracellular polysaccharide and intracellular polysaccharide in regulating intestinal microbial flora and reducing blood sugar | |
CN111265627B (en) | Sea cucumber polysaccharide composition for regulating intestinal flora and preparation method and application thereof | |
CN113476525A (en) | Traditional Chinese medicine glucoside composition with lipid-lowering and weight-losing effects and preparation method and application thereof | |
CN106038666A (en) | Bitter melon leaf extract and application thereof | |
JP7409797B2 (en) | Promoting short-chain fatty acid production in the intestinal tract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210615 |